Zofran is an anti-nausea drug made by GlaxoSmithKline (GSK). The drug was approved in 1991 to treat cancer patients who developed nausea during chemotherapy treatments. Later, GSK began to market the drug of off-label (unapproved) uses, including pregnant women who had morning sickness. However, the company never did any clinical research or studies to determine whether the drug was safe for pregnant women or their fetus.
The U.S. government has fined GSK $1 billion for its off-label marketing practices.
Studies have proven that Zofran causes birth defects, including misshapen skulls, heart defects, club foot, and cleft palate. Any woman who took Zofran during her pregnancy and gave birth to a child with congenital birth defects should contact an experienced drug attorney. For a free consultation regarding a possible claim against Zofran, please call Mike at 913-789-7477.